Breast Cancer
News and reporting on breast cancer.
Paige Gets CE-IVD Mark, UK Regulatory Approval for Breast Cancer Biomarker Software
The software is designed to detect HER2 expression based on protein and mRNA levels on digital images of tissue samples.
Agendia Building Validation Data on ImPrint for Guiding Neoadjuvant Immunotherapy in Breast Cancer
Premium
The firm envisions marketing the 53-gene signature with its existing MammaPrint and BluePrint tests as a comprehensive platform for breast cancer treatment selection.
Daiichi Sankyo's Application for Enhertu in HER2-Low Breast Cancer to Commence European Review
If the new application is approved, it would expand the market for Enhertu to include about half of all metastatic breast cancers.
In Brief This Week: Agilent Technologies, Mission Bio, EQRx, Center for Breakthrough Medicines
News items for the week of June 13, 2022.
NICE Recommends Eli Lilly's Verzenio as Adjuvant Treatment for High-Risk, Early-Stage Breast Cancer
The agency recommended the CDK4/6 inhibitor plus hormone therapy for HR-positive, HER2-negative, early-stage breast cancer patients at high risk of recurrence.